Acute Lymphoblastic Leukemia in a Jehovah's Witness Girl.
- Author:
Chang Ho JEON
1
;
Kyoung Hwa LEE
;
Soon Yong LEE
Author Information
1. Department of Pediatrics, Inje University College of Medicine, Pusan Paik Hospital, Pusan, Korea. pedslee@ijnc.inje.ac.kr
- Publication Type:Case Report
- Keywords:
Acute Lymphoblastic Leukemia;
Jehovah's Witness;
Erythropoietin;
G-CSF
- MeSH:
Blood Transfusion;
Bone Marrow;
Child;
Drug Therapy;
Erythropoietin;
Female*;
Granulocyte Colony-Stimulating Factor;
Humans;
Leukemia;
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
- From:Korean Journal of Pediatric Hematology-Oncology
2003;10(1):105-109
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Recent advances in the treatment of leukemia are closely related to the development of intensive chemotherapy, which needs multiple blood transfusions during bone marrow suppression. Patients of the Jehovah's Witness refuse blood transfusions and therefore hematologists are faced with major dilemma in the treatment of these patients with leukemia. We report an 11-year-old girl of Jehovah's Witness with acute lymphoblastic leukemia, who refused blood transfusions during chemotherapy. She was treated by intensive chemotherapy and her remission and induction was successful with the support of G-CSF and erythropoietin. She has been in remission state for over 6 years since the completion of chemotherapy. We also made a brief review of related literatures.
